Tags

Type your tag names separated by a space and hit enter

Treatment of perimenstrual migraine with triptans: an update.
Curr Pain Headache Rep. 2012 Oct; 16(5):445-51.CP

Abstract

Pure menstrual migraine (PMM) and menstrually related migraine (MRM) are difficult challenges in migraine management. Triptans are a class of highly selective serotonin receptor agonists, which interfere with the pathogenesis of migraine and are effective in relieving the associated neurovegetative symptoms. In recent years triptans have been extensively proposed for the treatment of severe, disabling, and recurrent perimenstrual migraine attacks. This review summarizes the different levels of recommendations for the use of triptans in the treatment of perimenstrual migraine. This review is also intended to offer an updated reasonable guide to physicians treating perimenstrual migraine in daily practice.

Links

Publisher Full Text

Authors+Show Affiliations

Casolla B
Sapienza University, Advanced Molecular Diagnostic Unit, NESMOS Department, Sant'Andrea Hospital, Rome, Italy.
Lionetto L
No affiliation info available
Candela S
No affiliation info available
D'Alonzo L
No affiliation info available
Negro A
No affiliation info available
Simmaco M
No affiliation info available
Martelletti P
No affiliation info available

MeSH

FemaleHumansMigraine DisordersPremenstrual SyndromeRandomized Controlled Trials as TopicSumatriptanTreatment OutcomeTryptamines

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

22644903

Citation

Casolla, Barbara, et al. "Treatment of Perimenstrual Migraine With Triptans: an Update." Current Pain and Headache Reports, vol. 16, no. 5, 2012, pp. 445-51.
Casolla B, Lionetto L, Candela S, et al. Treatment of perimenstrual migraine with triptans: an update. Curr Pain Headache Rep. 2012;16(5):445-51.
Casolla, B., Lionetto, L., Candela, S., D'Alonzo, L., Negro, A., Simmaco, M., & Martelletti, P. (2012). Treatment of perimenstrual migraine with triptans: an update. Current Pain and Headache Reports, 16(5), 445-51. https://doi.org/10.1007/s11916-012-0280-0
Casolla B, et al. Treatment of Perimenstrual Migraine With Triptans: an Update. Curr Pain Headache Rep. 2012;16(5):445-51. PubMed PMID: 22644903.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Treatment of perimenstrual migraine with triptans: an update. AU - Casolla,Barbara, AU - Lionetto,Luana, AU - Candela,Serena, AU - D'Alonzo,Lidia, AU - Negro,Andrea, AU - Simmaco,Maurizio, AU - Martelletti,Paolo, PY - 2012/5/31/entrez PY - 2012/5/31/pubmed PY - 2013/7/9/medline SP - 445 EP - 51 JF - Current pain and headache reports JO - Curr Pain Headache Rep VL - 16 IS - 5 N2 - Pure menstrual migraine (PMM) and menstrually related migraine (MRM) are difficult challenges in migraine management. Triptans are a class of highly selective serotonin receptor agonists, which interfere with the pathogenesis of migraine and are effective in relieving the associated neurovegetative symptoms. In recent years triptans have been extensively proposed for the treatment of severe, disabling, and recurrent perimenstrual migraine attacks. This review summarizes the different levels of recommendations for the use of triptans in the treatment of perimenstrual migraine. This review is also intended to offer an updated reasonable guide to physicians treating perimenstrual migraine in daily practice. SN - 1534-3081 UR - https://www.unboundmedicine.com/medline/citation/22644903/Treatment_of_perimenstrual_migraine_with_triptans:_an_update_ L2 - https://dx.doi.org/10.1007/s11916-012-0280-0 DB - PRIME DP - Unbound Medicine ER -